厦门大学学者库

学者信息

吴彩胜 (CaiSheng Wu)

药学院

归档
2024
2023
2022
2021
2020
合作者

已发表成果：

WOK 论文 42 篇;中文核心 1 篇;其它论文 2 篇;

  • Toxic metabolites and metabolic soft spots of celastrol based on glutathione metabolic capture and high-resolution mass spectrometry

    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY,1742-5255,2023-12-15.
    Jiang, Xiaojuan; Yuan, Caixia; Ding, Rong; Lu, Di; Peng, Xiaoyu; Dong, Zhihao; Zhu, Chunyan; Lin, Y...
    WOS:001129785900001   10.1080/17425255.2023.2294042
    收录情况：SCIE

  • Injectable Supramolecular Hydrogels for In Situ Programming of Car-T Cells toward Solid Tumor Immunotherapy

    ADVANCED MATERIALS,0935-9648,2023-12-04.
    Zhu, Chunyan; Ke, Lingjie; Ao, Xiang; Chen, Ying; Cheng, Hongwei; Xin, Huhu; Xu, Xiang; Loh, Xian-J...
    WOS:001112609700001   EI:20234915159077   10.1002/adma.202310078
    收录情况：SCIE、EI

  • Rapid and accurate identification of adulterated ingredients in lotus root powder based on liquid chromatography-high resolution mass spectrometry and MS-IDF

    JOURNAL OF FOOD COMPOSITION AND ANALYSIS,0889-1575,2023-10.
    Bai, Xue; Yuan, Caixia; Dong, Jiyang; Jiang, Xiaojuan; Qian, Xiaoyu; He, Shaogui; Guo, Xiaodan; Tie...
    WOS:001053522900001   10.1016/j.jfca.2023.105576
    收录情况：SCIE

  • Liposomal doxorubicin and free doxorubicin <i>in vivo</i> quantitation method developed on CE-LIF and its application in pharmacokinetic analysis

    ELECTROPHORESIS,0173-0835,2023-08-14.
    Tie, Cai; Jiang, Xiaojuan; Zhu, Chunyan; Wu, Caisheng
    WOS:001047975300001   EI:20233414584976   10.1002/elps.202300076
    收录情况：SCIE、EI

  • Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study

    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY,1478-7210,2023-07-23.
    Guo, Xiaodan; Lin, Yihua; He, Fengming; Jin, Ying; Chen, Simian; Li, Ting; Wu, Caisheng; Zhang, Lin...
    WOS:001033693700001   10.1080/14787210.2023.2238899
    收录情况：SCIE

  • Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume II

    FRONTIERS IN PHARMACOLOGY,,2023-02-06.
    Lei, Chuqi; Kong, Xiangyi; Sullivan, Ryan J.; Wu, Caisheng; Wang, Dawei; Zhang, Lin
    WOS:000935994800001   10.3389/fphar.2023.1136373
    收录情况：SCIE

  • Engineered celastrol and plasmid co-delivery for in situ expression and targeted mitochondrial relocation of Nur77 protein towards effective drug resistance reversion

    Chemical Engineering Journal,1385-8947,2023-02-01.
    Liu, Minting; Luo, Zheng; Li, Zhiguo; Lai, Xiyu; Loh, Xian Jun; Wu, Caisheng; Li, Zibiao; Wu, Yun-L...
    WOS:000880095100003   EI:20224313004910   10.1016/j.cej.2022.139879
    收录情况：SCIE、EI

  • Global Xenobiotic Profiling of Rat Plasma Using Untargeted Metabolomics and Background Subtraction-Based Approaches: Method Evaluation and Comparison

    CURRENT DRUG METABOLISM,1389-2002,2023.
    Jiang, Xiaojuan; Chen, Simian; Zhu, Mingshe; Wu, Caisheng
    WOS:001052449900007   10.2174/1389200224666230508122240
    收录情况：SCIE